Literature DB >> 6470600

Postmarketing drug surveillance by record linkage in Tayside.

I K Crombie, S V Brown, J G Hamley.   

Abstract

The feasibility of conducting postmarketing drug surveillance by record linkage in Tayside was assessed. The key feature of the method is that all hospital discharge data are already computerised by the area health board and may be accessed through the unique community health number (CHNo) which has been allocated to all Tayside residents. The 12 861 prescriptions for cimetidine dispensed in Tayside over a nine month period were collected and the CHNo identified for 76%. These corresponded to 3802 individuals and their discharge data, together with those for an equal number of controls matched by age, sex, and general practitioner were retrieved from the computer. The expected excess of those diseases for which cimetidine is prescribed (peptic ulcer and oesophagitis) was observed. Other drug-disease associations were observed but may have been due to confounding and emphasise the inadequacy of community based controls. The major advantages of record linkage are, firstly, the low cost of the method, the present study costing just over pounds 12 000, and, secondly, the duration of patient follow up which may may be extended for as many years as required simply by rerunning the computer programs. To assemble large patient cohorts the study would have to be extended to other area health boards that are currently developing similar computer systems. Record linkage may provide a cost effective method for the follow up of patients to identify serious adverse drug reactions, particularly those that take several years to develop.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6470600      PMCID: PMC1052357          DOI: 10.1136/jech.38.3.226

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  11 in total

1.  Scottish hospital morbidity data. 3. Some suggestions for improvement of the accuracy.

Authors:  A R Patel; A W Hutcheon; G M Wilson
Journal:  Health Bull (Edinb)       Date:  1976-07

2.  Scottish hospital morbidity data. 1. Errors in diagnostic returns.

Authors:  A R Patel; G Gray; G D Lang; F G Baillie; L Fleming; G M Wilson
Journal:  Health Bull (Edinb)       Date:  1976-07

3.  Scottish hospital morbidity data. 2. An attempt to improve the standard of diagnostic entries and records in a medical unit.

Authors:  A W Hutcheon; G M Wilson
Journal:  Health Bull (Edinb)       Date:  1976-07

4.  Accuracy of Scottish hospital morbidity data.

Authors:  E Lockwood
Journal:  Br J Prev Soc Med       Date:  1971-05

5.  Postmarketing surveillance of adverse drug reactions in general practice. I: search for new methods.

Authors:  W H Inman
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-04

6.  Incidence of salivary gland tumours in Scotland: accuracy of national records.

Authors:  B Lennox; J A Clarke; F Drake; S W Ewen
Journal:  Br Med J       Date:  1978-03-18

7.  Peptic ulcer: the changing scene.

Authors:  I A Bouchier
Journal:  Scott Med J       Date:  1981-10       Impact factor: 0.729

8.  Record linkage for drug monitoring.

Authors:  D C Skegg; R Doll
Journal:  J Epidemiol Community Health       Date:  1981-03       Impact factor: 3.710

9.  Gastric and duodenal ulcer and their associated diseases.

Authors:  M J Langman; A R Cooke
Journal:  Lancet       Date:  1976-03-27       Impact factor: 79.321

10.  Postmarketing surveillance of the safety of cimetidine: 12 month mortality report.

Authors:  D G Colin-Jones; M J Langman; D H Lawson; M P Vessey
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-28
View more
  6 in total

Review 1.  Record-linkage for pharmacovigilance in Scotland.

Authors:  J M Evans; T M MacDonald
Journal:  Br J Clin Pharmacol       Date:  1999-01       Impact factor: 4.335

2.  25 years of the Committee on Safety of Medicines. An international perspective of the benefits.

Authors:  J L Bem; S M Wood; L West; M D Rawlins; A M Breckenridge
Journal:  Drug Saf       Date:  1990 May-Jun       Impact factor: 5.606

3.  The role of record linkage in post-marketing drug surveillance.

Authors:  I K Crombie
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

4.  Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts.

Authors:  R M Herings; A Bakker; B H Stricker; G Nap
Journal:  J Epidemiol Community Health       Date:  1992-04       Impact factor: 3.710

5.  Patients as a direct source of information on adverse drug reactions.

Authors:  A S Mitchell; D A Henry; R Sanson-Fisher; D L O'Connell
Journal:  BMJ       Date:  1988-10-08

Review 6.  Views of healthcare professionals to linkage of routinely collected healthcare data: a systematic literature review.

Authors:  Y M Hopf; C Bond; J Francis; J Haughney; P J Helms
Journal:  J Am Med Inform Assoc       Date:  2013-05-28       Impact factor: 4.497

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.